Antihypertensive and central nervous system depressant properties of 3-(gamma-p-fluorobenzoyl propyl) 2,3,4,4a,5,6-hexahydro-1(H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69-183, centpyraquin).
D000374:Aggression / Q000187:drug effects; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002090:Butyrophenones / Q000494:pharmacology*; D002415:Cats; D004285:Dogs; D000882:Haplorhini; D006801:Humans; D008251:Macaca; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009541:Nictitating Membrane / Q000294:innervation; D011719:Pyrazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D013564:Sympathetic Nervous System / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000959:Antihypertensive Agents; D002090:Butyrophenones; D011719:Pyrazines; D011804:Quinolines; D014149:Tranquilizing Agents; C006944:centpyraquin